Published on · Updated on · 3 min read
Substance Spotlight: Lisdexamfetamine And Its Impurities
Lisdexamfetamine at a glance: chemical identity, CAS numbers, impurities & related substances for quality control – reference standards from EUROBRAM.
Lisdexamfetamine is a pharmaceutical active substance used in medicinal products for the treatment of attention-deficit/hyperactivity disorder (ADHD). It is a prodrug of dexamfetamine and is commonly formulated as lisdexamfetamine dimesylate. Its chemical identity, stereochemistry and impurity profile are relevant to pharmaceutical quality control.
EUROBRAM can offer lisdexamfetamine, its impurities and related substances as analytical reference standards for laboratory applications.
Lisdexamfetamine Reference Standards from EUROBRAM
In line with its Compliance & Results approach, EUROBRAM can offer lisdexamfetamine, its impurities and related substances as reference standards for professional laboratory applications.
Laboratories seeking reference materials for lisdexamfetamine analysis can contact EUROBRAM to discuss the required chemical form, analytical application and documentation requirements.
The specific material identity, available quantity, purity, accompanying documentation and supply conditions should be confirmed before ordering.
Chemical Identity, CAS Numbers and Alternative Names
Lisdexamfetamine consists of dexamfetamine covalently linked to the amino acid L-lysine. After administration, the prodrug is converted to active dexamfetamine.
The substance is used in prescription medicines, including Elvanse and Vyvanse. In the United States, lisdexamfetamine dimesylate is approved for ADHD and moderate-to-severe binge eating disorder in adults. Approved indications vary by jurisdiction.
The free base and its pharmaceutical salt have different chemical identifiers:
Property | Lisdexamfetamine | Lisdexamfetamine dimesylate |
|---|---|---|
CAS number | 608137-32-2 | 608137-33-3 |
Molecular formula | C₁₅H₂₅N₃O | C₁₇H₃₃N₃O₇S₂ |
Molecular weight | 263.38 g/mol | 455.59 g/mol |
PubChem CID | 11597698 | 11597697 |
Alternative names include lisdexamphetamine, L-lysine-d-amphetamine, lisdexamfetamine dimethanesulfonate (for the dimesylate) and the development designation NRP104.
Accurate identification of the chemical form is essential when selecting analytical reference materials, interpreting certificates of analysis and comparing laboratory results.
Lisdexamfetamine Impurities and Analytical Quality Control
Pharmaceutical analysis of lisdexamfetamine includes assessment of organic impurities, stereochemical purity and relevant process-related substances.
Examples described in United States Pharmacopeia (USP) analytical documentation include:
Lisdexamfetamine Related Compound A: a designated USP impurity reference standard
Lisdexamfetamine Related Compound B: a stereoisomeric impurity associated with enantiomeric purity testing.
Hydroxy lisdexamfetamine (Impurity M): an impurity identified in USP analytical research.
Isopropyl mesylate and propyl mesylate: process-related mesylate impurities relevant to impurity control.
Further lisdexamfetamine process-related impurities are:
Lisdexamfetamine Urea Impurity
Lisdexamfetamine Carbamate Impurity
Dexamfetamine / Dexamfetamine mesylate
Lisdexamfetamine Isomers and Salts
High-performance liquid chromatography (HPLC), including chiral chromatography, is used for assay, organic impurity testing and stereochemical analysis. Gas chromatography (GC) is described for determining certain mesylate impurities.
These substances are potential analytical targets and should not be interpreted as confirmed impurities in every pharmaceutical batch, as they can vary depending on the synthesis route.
Practical Relevance for Pharmaceutical Laboratories
Reliable reference materials support substance identification, analytical method development, method validation and quality control testing.
For lisdexamfetamine, laboratories must distinguish between the free base and dimesylate salt and consider the relevant impurity profile when choosing analytical standards.
Reference standards are particularly relevant to pharmaceutical manufacturers, contract research organizations, analytical testing laboratories and research institutions working with lisdexamfetamine-containing medicinal products.
Sources and Further Information
PubChem – Lisdexamfetamine. Chemical structure, molecular formula, CAS number and synonyms.
PubChem – Lisdexamfetamine Dimesylate. Pharmaceutical salt identity and chemical identifiers.
United States Pharmacopeia – Lisdexamfetamine Dimesylate. Analytical methods, impurity testing and reference standards.
USP Emerging Standards – Methods for the Analysis of Lisdexamfetamine. Analytical evaluation of lisdexamfetamine and related impurities.
DailyMed – VYVANSE Prescribing Information. Official US pharmaceutical labeling and approved indications.
Bhirud et al. reported 1,3-bis(1-methyl-2-phenylethyl)urea (formula VII) and (1-methyl-2-phenylethyl)carbamic acid isobutyl ester (formula VIII) as impurities detected by HPLC in a crude diamino-protected intermediate used in lisdexamfetamine manufacture (WO 2013/011526 A1, pp. 7–8).
Questions about your project?
Talk to EUROBRAM about pharmaceutical sourcing, regulatory documentation, and international supply chain solutions.